Monday, October 21, 2019 11:59:39 PM
Are you trying to be an idiot.
I already covered this a provided NHP data of GT3 usage for anti-radiation which showed GT3 was not effective in the NHP model and thus would not likely be effective in the Human situtation.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151176347
Copied from my prior post of the NHP study:
"In brief, 16 out of 24 vehicle-treated animals survived while 18 out of 24 GT3-treated animals survived, and differences between survivors of GT3- and vehicle-treated animals were not significant"
https://www.rrjournal.org/doi/full/10.1667/RR14127.1
And again there is no significant difference in overall survival of irradiated NHPs treated with vehicle or GT3 out to day 60.
"In this study, GT3 treatment did not significantly improve survival of irradiated animals."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM